Muhammad Mamdani

Senior Adjunct Scientist

ICES Affiliation

ICES UofT
Chronic Disease & Pharmacotherapy Research Program

Phone
416-864-6060 Ext. 76203

Other Affiliations

Director, Li Ka Shing Centre for Healthcare Analytics Research and Training, St. Michael's Hospital

Scientist, Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital

Associate Professor, Leslie Dan Faculty of Pharmacy, University of Toronto

Professor, Institute of Health Policy, Management and Evaluation, University of Toronto

Recent ICES Grants

Studies on the safety of prescription opioids

Principal investigator: Juurlink DN
Co-investigator: Gomes T, Mamdani M, Paterson M, Zipursky JS

Canadian Institutes of Health Research, Project Grant
2019-2021; $120,000

The Ontario Naloxone Program for Pharmacies (ONPP): a multiple method evaluation of naloxone distribution, access, program acceptability and risk avoidance

Principal investigators: Antoniou T, Gomes T, Wong A
Co-investigators: Juurlink D, Leece P, Lum-Wilson N, Mamdani M, Tadrous M

Canadian Institutes of Health Research, Operating Grant: Evaluation of Interventions to Address the Opioid Crisis
2019-2020; $100,000

Improving healthcare system efficiency and sustainability through pharmaceutical policy: the Ontario Drug Policy Research Network

Principal investigators: Gomes T, Mamdani M

Ministry of Health and Long-Term Care, Health System Research Fund
2017-2021; $1,908,539

Recent Awards & Recognition

Canada's Top 40 Under 40

2010: Awarded to Dr. Muhammad Mamdani for his research work by Caldwell Partners. Read about Dr. Mamdani and the prize.

4/27/2011

3/24/2019

The impact of randomized trial results on abdominal aortic aneurysm repair rates from 2003 to 2016: a population-based time-series analysis

Salata K, Hussain MA, de Mestral C, Greco E, Mamdani M, Tu JV, Forbes TL, Bhatt DL, Verma S, Al-Omran M. Vascular. 2019; Mar 24 [Epub ahead of print]. DOI: 10.1177/1708538119829582.

3/14/2019

Impact of delisting high‐strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada

Martins D, Khuu W, Tadrous M, Juurlink DN, Mamdani MM, Paterson JM, Gomes T. Pharmacoepidemiol Drug Saf. 2019; 28(5):726-33. Epub 2019 Mar 14. DOI: 10.1002/pds.4764.

2/8/2019

Evaluation of the fentanyl patch-for-patch program in Ontario, Canada

Tadrous M, Greaves S, Martins D, Nadeem K, Singh S, Mamdani MM, Juurlink DN, Gomes T. Int J Drug Policy. 2019; 66:82-6. Epub 2019 Feb 8.